A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Conditions: Castration-resistant Prostate Cancer; Non-small Cell Lung Cancer; Colorectal Cancer Interventions: Drug: SM08502; Drug: Abiraterone; Drug: Prednisone; Drug: Docetaxel; Drug: FOLFIRI Protocol; Drug: Panitumumab Sponsor: Biosplice Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Hormonal Therapy | Hormones | Prednisone | Research | Study | Taxotere